CellaVision AB

 STO:CEVI ISIN:SE0000683484

Feb 10, 2012

OVERVIEW |  NEWS |  MULTIMEDIA  | RESEARCH


 

CellaVision AB Company Summary

 

COMPANY DATA

 
Company Homepage www.cellavision.se
 

Key Developments: CellaVision AB
 CellaVision AB (STO:CEVI) CELLAVISION AB (publ) Interim Report For The Period January 1 - September 30, 2008
OCT 22, 2008 17:41 - Article Views: 244
CellaVision AB (STO:CEVI) Fifth consecutive quarter of profitability
 CellaVision AB (STO:CEVI) CellaVision And Sysmex Europe Extend Exclusive Distribution Agreement For The CellaVision® DM Products
OCT 7, 2008 16:33 - Article Views: 214
CellaVision AB (STO:CEVI) CellaVision AB (publ), which develops and sells digital morphology products for the routine analysis of blood and other body fluids, has extended its exclusive distribution agreement with Sysmex Europe for another two years in order to meet the growing demand for automated image analysis in Europe, the Middle East and Africa (EMEA).
 CellaVision AB (STO:CEVI) CellaVision Receives The First Canadian Orders For The New Body Fluid Application
SEP 30, 2008 16:33 - Article Views: 205
CellaVision AB (STO:CEVI) CellaVision AB (publ), which develops and sells digital morphology products for the routine analysis of blood and other body fluids, has received its first orders for the recently launched product, CellaVision® Body Fluid Application from Canada. The customers are all large hospital laboratories in the provinces of Ontario, British Columbia and Nova Scotia.
 CellaVision AB (STO:CEVI) Canadian Reference Laboratory Chooses CellaVision For Digital Image Analysis
SEP 29, 2008 16:33 - Article Views: 287
CellaVision AB (STO:CEVI) CellaVision AB (publ), which develops and sells digital morphology products for the routine analysis of blood and other body fluids, has signed an agreement with a leading reference laboratory in Canada to install CellaVision® DM96 analyzers at two of their medical service laboratories in Canada. The order comprises CellaVision DM96 analyzers for automation of the manual differential and CellaVision's software for remote access to patient's cell images.
 CellaVision AB (STO:CEVI) CellaVision Initiates Marketing Of Its Analyzers Into The Japanese market
SEP 3, 2008 16:33 - Article Views: 444
CellaVision AB (STO:CEVI) CellaVision, which develops and sells digital morphology products for the routine analysis of blood and other body fluids, has been given official approval for marketing the company's analyzers CellaVision® DM in Japan. The products will be marketed and sold by CellaVison's newly established subsidiary in Japan, CellaVision Japan K.K.
 CELLAVISION AB (publ) Interim Report For The Period January 1 - June 30, 2008
JULY 15, 2008 16:33 - Article Views: 228
CellaVision AB Several important contracts and positive earnings
 CellaVision Receives First Order From China
JUNE 30, 2008 16:33 - Article Views: 325
CellaVision AB CellaVision, which develops and sells digital morphology products for the routine analysis of blood and other body fluids, has via its Chinese distributor Vastec Medical Ltd officially been approved for sale of its analyzers in China. In connection to this, Vastec Medical has received its first order from Xijing Hospital i Xi'an.
 CellaVision Appoints New R&D Manager
JUNE 3, 2008 20:19 - Article Views: 284
CellaVision AB CellaVision AB, which develops and sells image-based products for routine analysis of blood and other body fluids, has appointed Adam Morell new R&D Manager, starting on 1 August, 2008.

70 COMPANY PROFILE VIEWS

 
This Page Viewed: (Since Published: 70) 
 

Site Search

 
 ENGLISH   All Languages

MARKETS

 

ABN Newswire on iPhone/iPad

Download from Apple

Mobile Video TV

qrcode
Scan with your Mobile Phone to view ABN Newswire Video Channel on Mobile
 
City Index - A Better Way To Trade